Related Experiment Video
Updated: Oct 2, 2025

04:41
Preparation of Oligomeric β-amyloid1-42 and Induction of Synaptic Plasticity Impairment on Hippocampal Slices
Published on: July 14, 2010
23.4K
Aβ-Induced Alterations in Membrane Lipids Occur before Synaptic Loss Appears
Michiel Van Bulck1,2, Nicola Brandt1, Ralf A Claus3
1Research Group Anatomy, School for Medicine and Health Science, Carl von Ossietzky University Oldenburg, 26129 Oldenburg, Germany.
International Journal of Molecular Sciences
|February 26, 2022
Summary
Amyloid-beta (Aβ) species alter membrane lipids before synaptic loss in brain cells. These lipid changes, particularly in sphingolipids and glycerophospholipids, may serve as early biomarkers for amyloidosis.
Area of Science:
- Neuroscience
- Biochemistry
- Cell Biology
Background:
- Synaptic loss and altered membrane lipids are hallmarks of aging and neurodegenerative diseases.
- Amyloid-beta (Aβ) aggregation, known as amyloidosis, is implicated in these cellular changes.
- The distinct roles of Aβ(1-40) and Aβ(1-42) species in synaptic and lipid alterations are not fully understood.
Purpose of the Study:
- To investigate the in vitro effects of Aβ species on synaptic loss and membrane lipid changes in hippocampal neurons and glial cells.
- To elucidate the time-dependent impact of Aβ on neuronal and glial membrane lipid profiles.
- To determine if synaptic loss is dependent on specific Aβ species.
Main Methods:
- In vitro treatment of hippocampal neurons and glial cells with Aβ(1-40) and Aβ(1-42) species.
- Lipidomic analysis to identify changes in membrane lipid composition.
- Assessment of active synapse loss.
Main Results:
- Aβ(1-40) or Aβ(1-42) treatment induced changes in membrane lipids prior to observable synaptic loss.
- Synaptic loss was not found to be dependent on the specific Aβ species used.
- Early alterations in specific lipid classes, including sphingolipids and glycerophospholipids, were identified in neurons.
Conclusions:
- Membrane lipid dysregulation occurs before synaptic loss in the context of amyloidosis.
- Specific lipid classes, such as sphingolipids and glycerophospholipids, show early changes.
- Lipids represent potential early diagnostic biomarkers for amyloidosis-related disorders.
Related Concept Videos
Long-term Depression
2.7K
Long-term depression, or LTD, is one of the ways by which synaptic plasticity—changes in the strength of chemical synapses—can occur in the brain. LTD is the process of synaptic weakening that occurs over time between pre and postsynaptic neuronal connections. The synaptic weakening of LTD works in opposition to synaptic strengthening by long-term potentiation (LTP) and together are the main mechanisms that underlie learning and memory.
Calcium Ion Concentration Mechanism
If over...
Calcium Ion Concentration Mechanism
If over...
2.7K
Alzheimer's Disease: Overview
713
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
713

